These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 4330569)
21. [Depot corticotropin in a screening test for adrenocortical insufficiency. A comparison between depot-ACTH (Jaton prolongatum "A-L") and depot-tetracosactid (Synacthen Depot "Ciba")]. Jorgensen H Nord Med; 1971 May; 85(20):618-22. PubMed ID: 4325636 [No Abstract] [Full Text] [Related]
22. [Melanoderma as a side effect of cortisone depot therapy]. Rainova R; Kaloianov K Vutr Boles; 1974; 13(2):120-2. PubMed ID: 4370659 [No Abstract] [Full Text] [Related]
23. [Why is one ACTH-preparation worse than another in asthma?]. Kjellson L Lakartidningen; 1996 Aug; 93(32-33):2726. PubMed ID: 8765591 [No Abstract] [Full Text] [Related]
24. [Practical experiences of long-term therapy with a new depot-glucocorticosteroid. (Depot-betamethasone-celestone-chronodose)]. Budde C; Lehner H Praxis; 1968 Oct; 57(39):1344-7. PubMed ID: 5756754 [No Abstract] [Full Text] [Related]
34. [Treatment with depot Medrol of bronchial asthma]. Lazidi GKh; Iakovenko SN Vrach Delo; 1973 Dec; 12():78-81. PubMed ID: 4787486 [No Abstract] [Full Text] [Related]
35. [Clinical and pharmacologic studies of synthetic ACTH]. Bíró L; Iván E; Sándor P; Perényi T Orv Hetil; 1971 Jun; 112(23):1327-9. PubMed ID: 4327819 [No Abstract] [Full Text] [Related]
36. [Use of delayed-action Cortrosyn (Tetracosactide) in rheumatology. Apropos of 32 cases]. Lièvre JA; Guillien P Brux Med; 1970 Dec; 50(12):1103-12. PubMed ID: 4322894 [No Abstract] [Full Text] [Related]
37. [Effect of a tetracosactide with depot action in the asthmatic syndrome]. Illig H Med Klin; 1970 May; 65(20):985-7. PubMed ID: 4325139 [No Abstract] [Full Text] [Related]